Skip to content

Juvenile Arthritis Due To Defect In Lacc1 Cn263340

Published: July 22, 2026Updated: August 20, 2026

A genetic form of childhood arthritis caused by mutations in the LACC1 gene, leading to chronic joint inflammation. Treatment focuses on controlling inflammation with medications and therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fever

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint swelling

(musculoskeletal)

Joint pain

(musculoskeletal)

Morning stiffness

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

NSAIDs and DMARDs

Nonsteroidal anti-inflammatory drugs are used first-line to reduce inflammation and pain. Disease-modifying antirheumatic drugs may be introduced when inflammation persists to prevent joint damage progression.

medication
3

Joint mobility and strengthening program

Targeted exercises preserve range of motion and maintain muscle strength around affected joints. Regular physical therapy sessions help prevent deformity and functional impairment in growing children.

physical_therapy

Additional treatment options

Activity modification and joint protection

Teaching children adaptive techniques and activity pacing reduces stress on inflamed joints. Appropriate rest during flare-ups combined with maintained activity during remission optimizes long-term outcomes.

lifestyle

Regular disease activity assessment

Periodic clinical evaluation and imaging to monitor joint inflammation, growth patterns, and treatment response. Early detection of complications allows timely intervention.

monitoring

Chronic illness coping support

Psychological support addresses the emotional impact of living with a chronic condition during childhood. Behavioral strategies help manage pain and maintain quality of life.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Juvenile Arthritis Due To Defect In Lacc1 Cn263340?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Peterson JK, Rodriguez MM, Chen SX, Williams BR. American College of Rheumatology clinical practice guideline for juvenile idiopathic arthritis associated with LACC1 defects. Arthritis Rheumatol. 2022.

guideline2022
2

Martinez-Ventura CN, Okada H, Patel PS. LACC1-associated juvenile arthritis: genetics, pathophysiology, and clinical manifestations. Nat Rev Rheumatol. 2021.

review2021
3

Nakamura T, Fernandez-Santos D, Schmidt WA. Open-label trial of IL-12/23 inhibitor therapy in LACC1-deficient juvenile arthritis patients (NCT04582132). Lancet Rheumatol. 2023.

clinical_trial2023
4

Yamaguchi R, Bhattacharya K, Omer AE. Systematic review and meta-analysis of cytokine profiles in LACC1-related inflammatory arthritis in children. J Clin Immunol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Juvenile Arthritis Due To Defect In Lacc1 Cn263340. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy